FR2698873B1 - Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. - Google Patents

Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.

Info

Publication number
FR2698873B1
FR2698873B1 FR9214720A FR9214720A FR2698873B1 FR 2698873 B1 FR2698873 B1 FR 2698873B1 FR 9214720 A FR9214720 A FR 9214720A FR 9214720 A FR9214720 A FR 9214720A FR 2698873 B1 FR2698873 B1 FR 2698873B1
Authority
FR
France
Prior art keywords
pct
group
activators
potassium channels
benzothiepins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9214720A
Other languages
English (en)
French (fr)
Other versions
FR2698873A1 (fr
Inventor
Jean-Jacques Berthelon
Marc Brunet Michelnoblet
Philippe Durbin
Daniel Guerrier
Nghia Luong Trong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Priority to FR9214720A priority Critical patent/FR2698873B1/fr
Priority to SI9300632A priority patent/SI9300632A/sl
Priority to LTIP1525A priority patent/LT3167B/lt
Priority to CN93120135A priority patent/CN1050127C/zh
Priority to IL10789193A priority patent/IL107891A0/xx
Priority to ZA939127A priority patent/ZA939127B/xx
Priority to CZ941848A priority patent/CZ184894A3/cs
Priority to KR1019940702708A priority patent/KR100236810B1/ko
Priority to HU9402302A priority patent/HUT67852A/hu
Priority to DE69324001T priority patent/DE69324001T2/de
Priority to DK94902708T priority patent/DK0626954T3/da
Priority to RO94-01321A priority patent/RO113040B1/ro
Priority to FI943646A priority patent/FI943646A0/fi
Priority to JP6513771A priority patent/JPH07503977A/ja
Priority to RU94040853A priority patent/RU2127268C1/ru
Priority to TW082110417A priority patent/TW276255B/zh
Priority to EP94902708A priority patent/EP0626954B1/en
Priority to PL93304719A priority patent/PL174246B1/pl
Priority to AU56975/94A priority patent/AU680856B2/en
Priority to SK939-94A priority patent/SK93994A3/sk
Priority to ES94902708T priority patent/ES2132373T3/es
Priority to AT94902708T priority patent/ATE177742T1/de
Priority to PCT/EP1993/003445 priority patent/WO1994013658A2/en
Priority to CA002129642A priority patent/CA2129642A1/en
Priority to US08/284,454 priority patent/US5602152A/en
Priority to NZ258896A priority patent/NZ258896A/en
Publication of FR2698873A1 publication Critical patent/FR2698873A1/fr
Priority to LVP-94-154A priority patent/LV10451B/en
Priority to NO942914A priority patent/NO942914L/no
Application granted granted Critical
Publication of FR2698873B1 publication Critical patent/FR2698873B1/fr
Priority to US08/460,866 priority patent/US5652252A/en
Priority to GR990401589T priority patent/GR3030514T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9214720A 1992-07-12 1992-12-07 Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant. Expired - Fee Related FR2698873B1 (fr)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FR9214720A FR2698873B1 (fr) 1992-12-07 1992-12-07 Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
SI9300632A SI9300632A (en) 1992-12-07 1993-12-03 Benzocycloheptenes, benzoxepines and benzothiepines
LTIP1525A LT3167B (en) 1992-12-07 1993-12-03 Benzocycloheptenes,benzoxepines and benzothiepines
IL10789193A IL107891A0 (en) 1992-12-07 1993-12-06 Benzocycloheptenes, benzoxepines and benzothiepines
ZA939127A ZA939127B (en) 1992-12-07 1993-12-06 Benzocycloheptenes benzoxepines and benzothiepines
CN93120135A CN1050127C (zh) 1992-12-07 1993-12-06 苯并环庚烯和苯并氧杂䓬其制备方法和含有它们的药物组合物
AT94902708T ATE177742T1 (de) 1992-12-07 1993-12-07 Benzocycloheptine, benzoxepine und benzothiepine
HU9402302A HUT67852A (en) 1992-12-07 1993-12-07 New benzocycloheptenes, and benzoxepines, pharmaceutical compositions containing them and process for producing them
DE69324001T DE69324001T2 (de) 1992-12-07 1993-12-07 Benzocycloheptine, benzoxepine und benzothiepine
DK94902708T DK0626954T3 (da) 1992-12-07 1993-12-07 Benzocycloheptener, benzoxepiner og benzothiepiner
RO94-01321A RO113040B1 (ro) 1992-12-07 1993-12-07 Derivati heterociclici de benzocicloheptene, benzoxepine sau benzotiepine, procedeu pentru prepararea acestora, compusi intermediari si compozitie farmaceutica
FI943646A FI943646A0 (fi) 1992-12-07 1993-12-07 Bentsosyklohepteenejä, bentsoksepiinejä bentsotiepiinejä
JP6513771A JPH07503977A (ja) 1992-12-07 1993-12-07 ベンゾシクロヘプテン，ベンゾキセピンおよびベンゾチエピン
RU94040853A RU2127268C1 (ru) 1992-12-07 1993-12-07 Производные бензоциклогептена или бензоксепина, способ их получения, промежуточные соединения и фармацевтическая композиция
TW082110417A TW276255B (index.php) 1992-12-07 1993-12-07
EP94902708A EP0626954B1 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines
CZ941848A CZ184894A3 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines and process for preparing thereof
AU56975/94A AU680856B2 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines
SK939-94A SK93994A3 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines and method their producing
ES94902708T ES2132373T3 (es) 1992-12-07 1993-12-07 Benzocicloheptenos, benzoxepinas y benzotiepinas.
KR1019940702708A KR100236810B1 (ko) 1992-12-07 1993-12-07 벤조사이클로헵텐
PCT/EP1993/003445 WO1994013658A2 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines
CA002129642A CA2129642A1 (en) 1992-12-07 1993-12-07 Benzocycloheptenes, benzoxepines and benzothiepines
US08/284,454 US5602152A (en) 1992-12-07 1993-12-07 Benzoxepines
NZ258896A NZ258896A (en) 1992-12-07 1993-12-07 Heterocyclic substituted benzoxepine and benzocycloheptene derivatives; pharmaceutical compositions thereof
PL93304719A PL174246B1 (pl) 1992-12-07 1993-12-07 Nowe związki, pochodne benzocykloheptenu, benzoksepiny i benzotiepiny
LVP-94-154A LV10451B (en) 1992-12-07 1994-08-05 Benzocycloheptenes, benzoxepines and benzothiepines and methods for preparation thereof
NO942914A NO942914L (no) 1992-12-07 1994-08-05 Benzosykloheptener, benzoksepiner og benzotiepiner
US08/460,866 US5652252A (en) 1992-07-12 1995-06-05 Benzocycloheptenes
GR990401589T GR3030514T3 (en) 1992-12-07 1999-06-15 Benzocycloheptenes, benzoxepines and benzothiepines.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214720A FR2698873B1 (fr) 1992-12-07 1992-12-07 Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.

Publications (2)

Publication Number Publication Date
FR2698873A1 FR2698873A1 (fr) 1994-06-10
FR2698873B1 true FR2698873B1 (fr) 1995-02-24

Family

ID=9436308

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9214720A Expired - Fee Related FR2698873B1 (fr) 1992-07-12 1992-12-07 Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.

Country Status (29)

Country Link
US (2) US5602152A (index.php)
EP (1) EP0626954B1 (index.php)
JP (1) JPH07503977A (index.php)
KR (1) KR100236810B1 (index.php)
CN (1) CN1050127C (index.php)
AT (1) ATE177742T1 (index.php)
AU (1) AU680856B2 (index.php)
CA (1) CA2129642A1 (index.php)
CZ (1) CZ184894A3 (index.php)
DE (1) DE69324001T2 (index.php)
DK (1) DK0626954T3 (index.php)
ES (1) ES2132373T3 (index.php)
FI (1) FI943646A0 (index.php)
FR (1) FR2698873B1 (index.php)
GR (1) GR3030514T3 (index.php)
HU (1) HUT67852A (index.php)
IL (1) IL107891A0 (index.php)
LT (1) LT3167B (index.php)
LV (1) LV10451B (index.php)
NO (1) NO942914L (index.php)
NZ (1) NZ258896A (index.php)
PL (1) PL174246B1 (index.php)
RO (1) RO113040B1 (index.php)
RU (1) RU2127268C1 (index.php)
SI (1) SI9300632A (index.php)
SK (1) SK93994A3 (index.php)
TW (1) TW276255B (index.php)
WO (1) WO1994013658A2 (index.php)
ZA (1) ZA939127B (index.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
BR9508916A (pt) * 1994-09-13 1997-12-30 Monsanto Co "Novas benzotiepinas tendo atividade como inibidores de transporte do ácido biliar ileal e absorção de taurocolato"
US6262277B1 (en) * 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6107494A (en) * 1994-09-13 2000-08-22 G.D. Searle And Company Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5952326A (en) * 1997-12-10 1999-09-14 Pfizer Inc. Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases
ATE295166T1 (de) * 1998-01-14 2005-05-15 Nippon Shinyaku Co Ltd Aktivatoren der kalium-kanäle
US6221897B1 (en) 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
EP1354604A1 (en) * 1998-12-23 2003-10-22 G.D. Searle LLC. Combinations for cardiovascular indications
NZ512534A (en) * 1998-12-23 2003-11-28 G Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
PL348508A1 (en) 1998-12-23 2002-05-20 Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
DK1140190T3 (da) * 1998-12-23 2002-12-23 Searle Llc Kombinationer af ileumgaldesyretransport-inhibitorer og galdesyre-sekvestreringsmidler til cardiovaskulære indikatorer
ES2200588T3 (es) 1998-12-23 2004-03-01 G.D. Searle Llc Combinacion de inhibidores del transporte de oxido biliar ileal y de derivados de acido fibrico para indicaciones cardiovasculares.
WO2000038722A1 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
EP1140185B1 (en) 1998-12-23 2003-06-04 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
PT1140184E (pt) 1998-12-23 2003-10-31 Searle Llc Combinacoes de inibidores de proteina de transferencia de ester de colesterilo com derivados de acido nicotinico para indicacoes cardiovasculares
WO2001068637A2 (en) 2000-03-10 2001-09-20 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
AU2001247331A1 (en) * 2000-03-10 2001-09-24 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
US20040077625A1 (en) * 2001-07-25 2004-04-22 Tremont Samuel J. Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
US6740663B2 (en) * 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
US6852753B2 (en) 2002-01-17 2005-02-08 Pharmacia Corporation Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
RU2387648C1 (ru) * 2008-12-15 2010-04-27 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" Способ получения алкиловых эфиров 3-оксо-1,3-дигидробензо[с]оксепин-4-карбоновой кислоты
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
BR112014010228B1 (pt) 2011-10-28 2020-09-29 Lumena Pharmaceuticals Llc Uso de inibidores de reciclagem de ácido biliar para o tratamento de hipercolemia e doença hepática colestática
US20150057452A1 (en) 2012-04-04 2015-02-26 Catylix, Inc. Selective androgen receptor modulators
KR102909548B1 (ko) * 2024-06-24 2026-01-07 정종기 변압기 압력조절장치

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593760A1 (de) * 1967-02-01 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Benz-epinderivate
US3444176A (en) * 1967-04-28 1969-05-13 Mcneilab Inc Certain 4-diloweralkylamino-lower alkyl - 5 - pyridyl (or phenyl)-2,3-dihydro - 1 - benzothiepins and derivatives thereof
AU8402275A (en) * 1974-08-26 1977-02-17 Takeda Chemical Industries Ltd Benzocycloheptene derivatives
US4066663A (en) * 1976-07-01 1978-01-03 Syntex (U.S.A.) Inc. 6,11-Dihydrodibenzo-[b. e.]-thiepin-11-one-3-aldehyde and 3-acetal derivatives
ATE23718T1 (de) 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
US4416687A (en) * 1982-02-01 1983-11-22 Monsanto Company 3,5-Bis (trifluoromethyl)phenoxy carboxylic acids and derivatives thereof
NZ207110A (en) * 1983-02-15 1986-05-09 Merrell Dow Pharma (4a,11b)-3,4,4a,5,6,11b-hexahydro-2h-(1)benzoxepino(5,4,b)-1,4-oxazine derivatives and pharmaceutical compositions
NZ219311A (en) * 1986-02-27 1989-04-26 Janssen Pharmaceutica Nv Imidazoles and herbicidal compositions
AU597671B2 (en) * 1986-06-20 1990-06-07 Suntory Limited 2-Phenylbenzoxepin derivative
DE3726261A1 (de) 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
US4971982A (en) 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
GB8812765D0 (en) * 1988-05-28 1988-06-29 Beecham Group Plc Novel compounds
DE3831697A1 (de) * 1988-09-17 1990-03-22 Hoechst Ag 2,3,4,5-tetrahydro-1-benzoxepine, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
JP3018386B2 (ja) * 1990-01-24 2000-03-13 吉富製薬株式会社 光学活性なベンゾチエピノピリダジン化合物の製造法

Also Published As

Publication number Publication date
SK93994A3 (en) 1995-04-12
KR100236810B1 (ko) 2000-02-01
US5602152A (en) 1997-02-11
DE69324001T2 (de) 1999-10-07
NO942914D0 (index.php) 1994-08-05
RU94040853A (ru) 1996-07-10
US5652252A (en) 1997-07-29
ZA939127B (en) 1994-08-05
RO113040B1 (ro) 1998-03-30
RU2127268C1 (ru) 1999-03-10
GR3030514T3 (en) 1999-10-29
EP0626954B1 (en) 1999-03-17
WO1994013658A2 (en) 1994-06-23
JPH07503977A (ja) 1995-04-27
CZ184894A3 (en) 1995-02-15
LV10451A (lv) 1995-02-20
LV10451B (en) 1995-12-20
AU5697594A (en) 1994-07-04
WO1994013658A3 (en) 1994-08-04
FI943646L (fi) 1994-08-05
KR950700278A (ko) 1995-01-16
LT3167B (en) 1995-02-27
CA2129642A1 (en) 1994-06-23
NZ258896A (en) 1996-03-26
TW276255B (index.php) 1996-05-21
PL174246B1 (pl) 1998-07-31
FI943646A7 (fi) 1994-08-05
FI943646A0 (fi) 1994-08-05
SI9300632A (en) 1994-09-30
HU9402302D0 (en) 1994-10-28
LTIP1525A (en) 1994-07-15
DE69324001D1 (de) 1999-04-22
IL107891A0 (en) 1994-04-12
EP0626954A1 (en) 1994-12-07
AU680856B2 (en) 1997-08-14
CN1050127C (zh) 2000-03-08
CN1097752A (zh) 1995-01-25
DK0626954T3 (da) 1999-10-11
FR2698873A1 (fr) 1994-06-10
NO942914L (no) 1994-08-05
HUT67852A (en) 1995-05-29
ES2132373T3 (es) 1999-08-16
ATE177742T1 (de) 1999-04-15
PL304719A1 (en) 1995-01-09

Similar Documents

Publication Publication Date Title
FR2698873B1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
BG101402A (en) Apoliprotein-b synthesis inhibitors
IL60715A0 (en) 4-phenoxypiperidines,process for their preparation and pharmaceutical compositions containing them
ATE179416T1 (de) 1-(arylalkyl-aminoalkyl) imidazolderivate, herstellungs verfahren und verwendung als therapeutische mittel
FR2696466B1 (fr) Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
AP2001002251A0 (en) 2-aminopyridines containing fused ring substituents.
ZA968280B (en) Disubstituted piperidine derivatives
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
ZA852874B (en) 1-(substituted-aryl)-dihydro-1h-pyrrolizine 3,5(2h,6h)-diones as cognition activators
ATE35538T1 (de) (substituierte phenyl)-5-oxo-2pyrrolidinpropions|uren, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
FR2721314B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
TH16053A (index.php)
JO1755B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse